123 related articles for article (PubMed ID: 19936238)
21. In or out of control: Modulating regulatory T cell homeostasis and function with immune checkpoint pathways.
Abdeladhim M; Karnell JL; Rieder SA
Front Immunol; 2022; 13():1033705. PubMed ID: 36591244
[TBL] [Abstract][Full Text] [Related]
22. Activated but functionally impaired memory Tregs are expanded in slow progressors to type 1 diabetes.
Boldison J; Long AE; Aitken RJ; Wilson IV; Megson C; Hanna SJ; Wong FS; Gillespie KM
Diabetologia; 2022 Feb; 65(2):343-355. PubMed ID: 34709423
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive review on the role of co-signaling receptors and Treg homeostasis in autoimmunity and tumor immunity.
Kumar P; Bhattacharya P; Prabhakar BS
J Autoimmun; 2018 Dec; 95():77-99. PubMed ID: 30174217
[TBL] [Abstract][Full Text] [Related]
24. TRI Microspheres prevent key signs of dry eye disease in a murine, inflammatory model.
Ratay ML; Balmert SC; Acharya AP; Greene AC; Meyyappan T; Little SR
Sci Rep; 2017 Dec; 7(1):17527. PubMed ID: 29235530
[TBL] [Abstract][Full Text] [Related]
25. Treg-recruiting microspheres prevent inflammation in a murine model of dry eye disease.
Ratay ML; Glowacki AJ; Balmert SC; Acharya AP; Polat J; Andrews LP; Fedorchak MV; Schuman JS; Vignali DAA; Little SR
J Control Release; 2017 Jul; 258():208-217. PubMed ID: 28501670
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA and mRNA Transcriptome Profiling in Primary Human Astrocytes Infected with Borrelia burgdorferi.
Casselli T; Qureshi H; Peterson E; Perley D; Blake E; Jokinen B; Abbas A; Nechaev S; Watt JA; Dhasarathy A; Brissette CA
PLoS One; 2017; 12(1):e0170961. PubMed ID: 28135303
[TBL] [Abstract][Full Text] [Related]
27. Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
Visperas A; Vignali DA
J Immunol; 2016 Nov; 197(10):3762-3770. PubMed ID: 27815439
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system.
Kobayashi Y; Kiguchi N; Fukazawa Y; Saika F; Maeda T; Kishioka S
J Biol Chem; 2015 May; 290(20):12603-13. PubMed ID: 25787078
[TBL] [Abstract][Full Text] [Related]
29. Correlation of increased blood levels of GITR and GITRL with disease severity in patients with primary Sjögren's syndrome.
Gan X; Feng X; Gu L; Tan W; Sun X; Lv C; Zhang M
Clin Dev Immunol; 2013; 2013():340751. PubMed ID: 23935647
[TBL] [Abstract][Full Text] [Related]
30. A diametric role for OX40 in the response of effector/memory CD4+ T cells and regulatory T cells to alloantigen.
Kinnear G; Wood KJ; Fallah-Arani F; Jones ND
J Immunol; 2013 Aug; 191(3):1465-75. PubMed ID: 23817421
[TBL] [Abstract][Full Text] [Related]
31. Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
Tian J; Ma J; Ma K; Ma B; Tang X; Baidoo SE; Tong J; Yan J; Lu L; Xu H; Wang S
PLoS One; 2012; 7(10):e46936. PubMed ID: 23077535
[TBL] [Abstract][Full Text] [Related]
32. Modulation of GITR for cancer immunotherapy.
Schaer DA; Murphy JT; Wolchok JD
Curr Opin Immunol; 2012 Apr; 24(2):217-24. PubMed ID: 22245556
[TBL] [Abstract][Full Text] [Related]
33. TNF superfamily in inflammatory disease: translating basic insights.
Croft M; Duan W; Choi H; Eun SY; Madireddi S; Mehta A
Trends Immunol; 2012 Mar; 33(3):144-52. PubMed ID: 22169337
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological modulation of GITRL/GITR system: therapeutic perspectives.
Nocentini G; Ronchetti S; Petrillo MG; Riccardi C
Br J Pharmacol; 2012 Apr; 165(7):2089-99. PubMed ID: 22029729
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune therapies targeting costimulation and emerging trends in multivalent therapeutics.
Chittasupho C; Siahaan TJ; Vines CM; Berkland C
Ther Deliv; 2011 Jul; 2(7):873-89. PubMed ID: 21984960
[TBL] [Abstract][Full Text] [Related]
36. Alterations of peripheral CD4+CD25+Foxp3+ T regulatory cells in mice with STZ-induced diabetes.
Zhen Y; Sun L; Liu H; Duan K; Zeng C; Zhang L; Jin D; Peng J; Ding W; Zhao Y
Cell Mol Immunol; 2012 Jan; 9(1):75-85. PubMed ID: 21983870
[TBL] [Abstract][Full Text] [Related]
37. Th2 responses to helminth parasites can be therapeutically enhanced by, but are not dependent upon, GITR-GITR ligand costimulation in vivo.
van der Werf N; Redpath SA; Phythian-Adams AT; Azuma M; Allen JE; Maizels RM; Macdonald AS; Taylor MD
J Immunol; 2011 Aug; 187(3):1411-20. PubMed ID: 21705620
[TBL] [Abstract][Full Text] [Related]
38. An update on the use of NOD mice to study autoimmune (Type 1) diabetes.
Chaparro RJ; Dilorenzo TP
Expert Rev Clin Immunol; 2010 Nov; 6(6):939-55. PubMed ID: 20979558
[TBL] [Abstract][Full Text] [Related]
39. Glucocorticoid-induced TNFR-related (GITR) protein and its ligand in antitumor immunity: functional role and therapeutic modulation.
Placke T; Kopp HG; Salih HR
Clin Dev Immunol; 2010; 2010():239083. PubMed ID: 20936139
[TBL] [Abstract][Full Text] [Related]
40. Depletion of regulatory T cells by anti-GITR mAb as a novel mechanism for cancer immunotherapy.
Coe D; Begom S; Addey C; White M; Dyson J; Chai JG
Cancer Immunol Immunother; 2010 Sep; 59(9):1367-77. PubMed ID: 20480365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
